These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 9811680)

  • 21. Does the antitumor adenovirus ONYX-015/dl1520 selectively target cells defective in the p53 pathway?
    Dix BR; Edwards SJ; Braithwaite AW
    J Virol; 2001 Jun; 75(12):5443-7. PubMed ID: 11356950
    [No Abstract]   [Full Text] [Related]  

  • 22. Control of p53 expression by adenovirus 12 early region 1A and early region 1B 54K proteins.
    Grand RJ; Owen D; Rookes SM; Gallimore PH
    Virology; 1996 Apr; 218(1):23-34. PubMed ID: 8615026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting the replication of adenoviral gene therapy vectors to lung cancer cells: the importance of the adenoviral E1b-55kD gene.
    Hay JG; Shapiro N; Sauthoff H; Heitner S; Phupakdi W; Rom WN
    Hum Gene Ther; 1999 Mar; 10(4):579-90. PubMed ID: 10094201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy.
    Rogulski KR; Freytag SO; Zhang K; Gilbert JD; Paielli DL; Kim JH; Heise CC; Kirn DH
    Cancer Res; 2000 Mar; 60(5):1193-6. PubMed ID: 10728673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p14(ARF) modulates the cytolytic effect of ONYX-015 in mesothelioma cells with wild-type p53.
    Yang CT; You L; Uematsu K; Yeh CC; McCormick F; Jablons DM
    Cancer Res; 2001 Aug; 61(16):5959-63. PubMed ID: 11507034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The early region 1B 55-kilodalton oncoprotein of adenovirus relieves growth restrictions imposed on viral replication by the cell cycle.
    Goodrum FD; Ornelles DA
    J Virol; 1997 Jan; 71(1):548-61. PubMed ID: 8985383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer.
    Wills KN; Maneval DC; Menzel P; Harris MP; Sutjipto S; Vaillancourt MT; Huang WM; Johnson DE; Anderson SC; Wen SF
    Hum Gene Ther; 1994 Sep; 5(9):1079-88. PubMed ID: 7833367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial.
    Nemunaitis J; Ganly I; Khuri F; Arseneau J; Kuhn J; McCarty T; Landers S; Maples P; Romel L; Randlev B; Reid T; Kaye S; Kirn D
    Cancer Res; 2000 Nov; 60(22):6359-66. PubMed ID: 11103798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of replication-competent adenovirus isolates from large-scale production of a recombinant adenoviral vector.
    Zhu J; Grace M; Casale J; Chang AT; Musco ML; Bordens R; Greenberg R; Schaefer E; Indelicato SR
    Hum Gene Ther; 1999 Jan; 10(1):113-21. PubMed ID: 10022536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of a replication-selective adenovirus against ovarian carcinomatosis is dependent on tumor burden, viral replication and p53 status.
    Heise C; Ganly I; Kim YT; Sampson-Johannes A; Brown R; Kirn D
    Gene Ther; 2000 Nov; 7(22):1925-9. PubMed ID: 11127580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dl1520 virus is found preferentially in tumor tissue after direct intratumoral injection in oral carcinoma.
    Morley S; MacDonald G; Kirn D; Kaye S; Brown R; Soutar D
    Clin Cancer Res; 2004 Jul; 10(13):4357-62. PubMed ID: 15240522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncolytic E1B 55KDa-deleted adenovirus replication is independent of p53 levels in cancer cells.
    Abbas BM; El-Mogy MA; Haj-Ahmad Y
    Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(7):1-11. PubMed ID: 28838332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. E1B-55K-deleted adenovirus expressing E1A-13S by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor.
    Takahashi M; Sato T; Sagawa T; Lu Y; Sato Y; Iyama S; Yamada Y; Fukaura J; Takahashi S; Miyanishi K; Yamashita T; Sasaki K; Kogawa K; Hamada H; Kato J; Niitsu Y
    Mol Ther; 2002 May; 5(5 Pt 1):627-34. PubMed ID: 11991754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The replicative capacities of large E1B-null group A and group C adenoviruses are independent of host cell p53 status.
    Turnell AS; Grand RJ; Gallimore PH
    J Virol; 1999 Mar; 73(3):2074-83. PubMed ID: 9971789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I trial of intraperitoneal injection of the E1B-55-kd-gene-deleted adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent/refractory epithelial ovarian cancer.
    Vasey PA; Shulman LN; Campos S; Davis J; Gore M; Johnston S; Kirn DH; O'Neill V; Siddiqui N; Seiden MV; Kaye SB
    J Clin Oncol; 2002 Mar; 20(6):1562-9. PubMed ID: 11896105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cytotoxic effect of E1B 55-kDa mutant adenovirus on human hepatocellular carcinoma cell lines.
    Zhao J; Wang H; Wei L; Habib NA; Lu X; Wu M; Guo Y
    Cancer Gene Ther; 2001 May; 8(5):333-41. PubMed ID: 11477453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E1B-55-kilodalton protein is not required to block p53-induced transcription during adenovirus infection.
    Hobom U; Dobbelstein M
    J Virol; 2004 Jul; 78(14):7685-97. PubMed ID: 15220443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of oncolytic mutants targeting pRb and p53 pathways is synergistically enhanced when combined with cytotoxic drugs in prostate cancer cells and tumor xenografts.
    Radhakrishnan S; Miranda E; Ekblad M; Holford A; Pizarro MT; Lemoine NR; Halldén G
    Hum Gene Ther; 2010 Oct; 21(10):1311-25. PubMed ID: 20497039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cells.
    Li LX; Zhang YL; Zhou L; Ke ML; Chen JM; Fu X; Ye CL; Wu JX; Liu RY; Huang W
    J Transl Med; 2013 Oct; 11():257. PubMed ID: 24124726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
    Wildner O; Morris JC
    Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.